Recombinant human nerve growth factor (Beijing Tongren Hospital)

N/A

Report date: 2024/12/18 10:01:47

Base Information

Drug NameRecombinant human nerve growth factor (Beijing Tongren Hospital)
Drug Alias NameN/A
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionNerve growth factor receptors agonists
TargetsNerve growth factor receptors
Therapy Area/IndicationsOptic Nerve Injuries
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaPending
Originator CompaniesBeijing Tongren Hospital, Cmu
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBeijing Tongren Hospital, Cmu
Active IndicationsN/A
Inactive IndicationsOptic Nerve Injuries

Other Information

ATC CodeN/A
Related LinksN/A